Astellas Pharma US Inc. recalls Astagraf XL (tacrolimus extended-release capsules) 0.5 mg
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
- Products
-
- Astagraf XL (tacrolimus extended-release capsules) 0.5 mg
- Company
- Astellas Pharma US Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 3,500 30-count bottles
- About this recall
- Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.